Collateral vessel density modulates arteriovenous malformation severity
Arteriovenous malformations (AVMs) are high-flow vascular anomalies defined by direct artery-to-vein shunts, often resulting in hemodynamic instability, vessel rupture, and life-threatening hemorrhage. Causative mutations in ENG, ALK1, and SMAD4 are well-established in hereditary hemorrhagic telangiectasia (HHT), yet AVM severity varies widely among individuals carrying the same mutation, implicating host-specific modifiers that remain poorly defined. Here we test whether collateral vessel density modifies AVM severity in vivo. Using Rabep2-knockout mice, which have reduced collateral vessel density, we examined AVM severity in two independent AVM mouse models (Eng-and Alk1-inducible knockouts). Rabep2 deletion significantly reduced the number of pial and dorsal skin collaterals; this was accompanied by attenuated AVM formation, with smaller lesion volume and preserved hemoglobin levels. Collateral number correlated positively AVM severity at the individual animal level. In a retinal AVM model lacking native collaterals, Rabep2 deletion did not alter AVM formation, indicating that this effect requires a collateral network. These results identify collateral vessel density as a physiological modulator of AVM severity and suggest that vascular architecture and hemodynamics, rather than genetic signaling alone, shape AVM outcome.
Authors
- Douglas A. Marchuk (ORCID: https://orcid.org/0000-0002-3110-6671)
- Hyunwoo Choi (ORCID: https://orcid.org/0000-0002-2615-1961)
- Han Kyu Lee (ORCID: https://orcid.org/0000-0002-0876-7404)
- S. Paul Oh
Institutions
- Barrow Neurological Institute (US)
- Duke University (US)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-11578259/v1
- Primary Topic
- Vascular Anomalies and Treatments
- Type
- preprint
Funders
- U.S. Department of Defense
- University of Southern California
- Barrow Neurological Foundation
- Newcastle University
- Fondation Leducq